LCN2 and breast cancer: As shown in Fig. 6b, adding IL-1β antibody further reduced the colony number of LCN2-depleted MDA-MB-231 breast cancer cells co-cultured with MGDAs, suggesting that both IL-1β and LCN2 contribute to MGDAs-mediated tumour malignancy.